Insider Shareholders with Direct Ownership of Milestone Pharmaceuticals Inc. (MIST)
This section provides a comprehensive overview of the insiders with direct ownership of Milestone Pharmaceuticals Inc. (MIST). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Milestone Pharmaceuticals Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
2,674,470 | 240,000 | 2,434,470 $5.02 Million | 2 |
Nov 25, 2019
Reduced 8.97%
|
|
Joseph Oliveto
President and CEO |
413,266 | 211,077 | 482,744 $994,452 | 7 |
Jan 26, 2026
Reduced 6.67%
|
|
Lorenz Muller
Chief Commercial Officer |
186,766 | 89,746 | 205,406 $423,136 | 6 |
Jan 26, 2026
Reduced 5.16%
|
|
David Bharucha
Chief Medical Officer |
183,433 | 70,252 | 113,181 $233,152 | 7 |
Jan 26, 2026
Reduced 9.76%
|
| 100,000 | 0 | 100,000 $206,000 | 1 |
Jul 11, 2025
Added 50.0%
|
|
|
Amit Hasija
CFO & EVP of Corp. Development |
170,100 | 70,252 | 99,848 $205,686 | 5 |
Jan 26, 2026
Reduced 10.92%
|
|
Paul F Truex
Director |
81,780 | 0 | 81,780 $168,466 | 1 |
May 31, 2022
Added 5.76%
|
| 65,000 | 0 | 65,000 $133,900 | 2 |
Jul 11, 2025
Added 43.48%
|
|
|
Jeffrey Edward Nelson
Chief Operating Officer |
120,100 | 70,252 | 49,848 $102,686 | 4 |
Jan 26, 2026
Reduced 19.72%
|
| 16,793 | 0 | 16,793 $34,593 | 2 |
Jul 11, 2025
Added 49.81%
|
|
| 15,000 | 0 | 15,000 $30,900 | 1 |
Oct 19, 2022
Added 50.0%
|
|
|
Richard C Pasternak
Director |
10,000 | 0 | 10,000 $20,600 | 1 |
Oct 20, 2022
Added 50.0%
|